A Phase 3b, Randomized, Multicenter, Open-Label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-Acting Cabotegravir Plus Long-Acting Rilpivirine From Current Antiretroviral Regimen in HIV-1 Infected, Virologically Suppressed Adults in Sub-Saharan Africa

Projects
A Phase 3b, Randomized, Multicenter, Open-Label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-Acting Cabotegravir Plus Long-Acting Rilpivirine From Current Antiretroviral Regimen…
Read More

PICASSO

Projects
Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial   Co-National Principal Investigators Dr Simiso Sokhela (MBChB) Director: Clinical Research, Ezintsha, Wits Health Consortium University of the…
Read More

ChaLoC

Projects
A cross-sectional, observational study to characterise Long-COVID in an urban sample of South African adults Background “Long–COVID’’ (also known as post-COVID-19 syndrome, post-acute sequelae of…
Read More

Opti-DOR

Projects
A Randomised, Phase 3 Non-inferiority Study of DOR/3TC/TDF compared to DTG/TAF/FTC in Participants Infected with HIV-1 Starting First-line Antiretroviral Therapy Study Sites Multiple sites- in…
Read More

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of Budigalimab and/or ABBV-382 in People Living with HIV on Stable Antiretroviral Therapy Undergoing Analytical Treatment Interruption

Projects
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of Budigalimab and/or ABBV-382 in People Living with HIV on…
Read More